India Exim Bank signs $100m loan deal with JBIC

The purpose of this facility is to support India’s healthcare sector related to the fight against COVID-19

Export-Import Bank of India (India Exim Bank) has entered into a $100 million loan agreement with Japan Bank for International Cooperation (JBIC), as well as three Japanese private financial institutions, namely MUFG Bank, Ltd., Bank of Kyoto, Ltd. ., and Hachijuni Bank, Ltd., on May 23, 2022, on the sidelines of the Quad Leaders’ Summit.

The purpose of this facility is to support India’s healthcare sector related to the fight against COVID-19, including but not limited to vaccine manufacturers, pharmaceutical companies, protective equipment manufacturers personal, medical oxygen or other medical devices, hospitals and other related activities.

India Exim Bank and JBIC will jointly work to expand safe and efficient manufacturing of COVID-19 vaccines and related pharmaceuticals and healthcare products in India.

India Exim Bank supports the healthcare sector and all segments of the pharmaceutical value chain. In addition to supporting the domestic expansion projects of companies in these sectors, the bank has also supported the overseas efforts of various Indian companies in the healthcare sector (including hospitals and healthcare institutions, pathological laboratories and related training/education services), pharmaceutical companies (including bulk drug and formulation manufacturing), and biosimilar/biopharmaceutical companies (including life sciences), among others. Additionally, India Exim Bank supports research and development, new product development and other related fields.

Comments are closed.